Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation.

Abstract:

:The receptor tyrosine kinase FLT3 is expressed in myeloid and lymphoid progenitor cells. Activating mutations in FLT3 occur in 25-30% of acute myeloid leukaemia (AML) patients. Most common are internal tandem duplications of sequence (ITD) leading to constitutive FLT3-ITD kinase activity with an altered signalling quality promoting leukaemic cell transformation. Here, we observed the attenuating role of the receptor-like protein tyrosine phosphatase (RPTP) CD45/Ptprc in FLT3 signalling in vivo. Low level expression of this abundant RPTP correlates with a poor prognosis of FLT3-ITD-positive AML patients. To get a further insight into the regulatory role of Ptprc in FLT3-ITD activity in vivo, Ptprc knock-out mice were bred with FLT3-ITD knock-in mice. Inactivation of the Ptprc gene in FLT3-ITD mice resulted in a drastically shortened life span and development of severe monocytosis, a block in B-cell development and anaemia. The myeloproliferative phenotype was associated with extramedullary haematopoiesis, splenohepatomegaly and severe alterations of organ structures. The phenotypic alterations were associated with increased transforming signalling of FLT3-ITD, including activation of its downstream target STAT5. These data reveal the capacity of Ptprc for the regulation of FLT3-ITD signalling activity in vivo. In addition, histopathology and computed tomography (CT) revealed an unexpected bone phenotype; the FLT3-ITD Ptprc-/- mice, but none of the controls, showed pronounced alterations in bone morphology and, in part, apparent features of osteoporosis. In the spleen, ectopic bone formation was observed. The observed bone phenotypes suggest a previously unappreciated capacity of FLT3-ITD (and presumably FLT3) to regulate bone development/remodelling, which is under negative control of CD45/Ptprc.

journal_name

Oncogene

journal_title

Oncogene

authors

Kresinsky A,Schnöder TM,Jacobsen ID,Rauner M,Hofbauer LC,Ast V,König R,Hoffmann B,Svensson CM,Figge MT,Hilger I,Heidel FH,Böhmer FD,Müller JP

doi

10.1038/s41388-019-0757-y

subject

Has Abstract

pub_date

2019-06-01 00:00:00

pages

4773-4787

issue

24

eissn

0950-9232

issn

1476-5594

pii

10.1038/s41388-019-0757-y

journal_volume

38

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.

    abstract::The E3 ligase S-phase kinase-associated protein 2(Skp2) is overexpressed in human cancers and correlated with poor prognosis, but its contributions to tumorigenesis and chemoresistance in nasopharyngeal carcinoma (NPC) are not evident. Herein we show that Skp2 is highly expressed in NPC tumor tissues and cell lines. K...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0955-7

    authors: Yu X,Wang R,Zhang Y,Zhou L,Wang W,Liu H,Li W

    更新日期:2019-12-01 00:00:00

  • Identification of RASSF8 as a candidate lung tumor suppressor gene.

    abstract::The RASSF8 gene, which maps close to the KRAS2 gene, contains a RAS-associated domain and encodes a protein that is evolutionarily conserved from fish to humans. Analysis of the RASSF8 transcript revealed a complex expression pattern of 5'-UTR mRNA isoforms in normal lung and in lung adenocarcinomas (ADCAs), with no a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209422

    authors: Falvella FS,Manenti G,Spinola M,Pignatiello C,Conti B,Pastorino U,Dragani TA

    更新日期:2006-06-29 00:00:00

  • Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.

    abstract::The natural phytoalexin resveratrol (3, 5, 4'-trihydroxystilbene) exhibits both chemopreventive and antitumor activities through a variety of mechanisms. We have shown previously that resveratrol-induced apoptosis of a human colon cancer cell line involved the redistribution of CD95 (Fas/Apo-1) into lipid rafts. Here,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208086

    authors: Delmas D,Rébé C,Micheau O,Athias A,Gambert P,Grazide S,Laurent G,Latruffe N,Solary E

    更新日期:2004-11-25 00:00:00

  • Accumulated helix-destabilizing mutations in the leucine zipper of c-Fos leads to attenuation and temperature sensitivity of function.

    abstract::Fos protein heterodimerizes through one surface of an alpha-helical domain called the leucine zipper. We have investigated the effect of destabilizing this domain by multiply substituting small residues of its non-interacting surface with glycine. Ternary complex formation between mutated Fos, Jun and DNA was determin...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Nicklin MJ,Zechner D,Kislyakova T

    更新日期:1993-07-01 00:00:00

  • RARgamma acts as a tumor suppressor in mouse keratinocytes.

    abstract::All-trans retinoic acid (RA), the principle biologically active form of vitamin A, is essential for many developmental process as well as homeostasis in the adult. Many lines of evidence also suggest that RA, acting through the RA receptors (RARs), can also suppress growth of tumors of diverse origin. To assess direct...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207682

    authors: Chen CF,Goyette P,Lohnes D

    更新日期:2004-07-08 00:00:00

  • Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge.

    abstract::The tumor-stroma crosstalk is a dynamic process fundamental in tumor development. In hepatocellular carcinoma (HCC), the progression of malignant hepatocytes frequently depends on transforming growth factor (TGF)-beta provided by stromal cells. TGF-beta induces an epithelial to mesenchymal transition (EMT) of oncogeni...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.253

    authors: van Zijl F,Mair M,Csiszar A,Schneller D,Zulehner G,Huber H,Eferl R,Beug H,Dolznig H,Mikulits W

    更新日期:2009-11-12 00:00:00

  • Translocation of activated Rho from the cytoplasm to membrane ruffling area, cell-cell adhesion sites and cleavage furrows.

    abstract::Rho small GTP-binding protein regulates various cell functions, such as formation of stress fibers and focal adhesions, cell motility, membrane ruffling, cytokinesis and smooth muscle contraction in mammalian cells and bud formation in the yeast Saccharomyces cerevisiae. As to the functioning sites of Rho in Saccharom...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Takaishi K,Sasaki T,Kameyama T,Tsukita S,Tsukita S,Takai Y

    更新日期:1995-07-06 00:00:00

  • Alternate mechanisms of ras activation are complementary and favor and formation of ras-GTP.

    abstract::The mechanisms of ras activation by mutations in residue 61 and in the NKXD guanine nucleotide-binding consensus sequence (ras residues 116-119) have been evaluated. Weakly transforming mutations that either reduce intrinsic and GTPase-activating protein (GAP)-stimulated GTPase activities (61P) or enhance guanine nucl...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Patel G,MacDonald MJ,Khosravi-Far R,Hisaka MM,Der CJ

    更新日期:1992-02-01 00:00:00

  • DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.

    abstract::Sal-like protein 4 (SALL4), an embryonic stem cell transcriptional regulator, is re-expressed by an unknown mechanism in poor prognosis hepatocellular carcinoma (HCC), often associated with chronic hepatitis B virus (HBV) infection. Herein, we investigated the mechanism of SALL4 re-expression in HBV-related HCCs. We p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.399

    authors: Fan H,Cui Z,Zhang H,Mani SK,Diab A,Lefrancois L,Fares N,Merle P,Andrisani O

    更新日期:2017-04-27 00:00:00

  • DNA damage signalling guards against activated oncogenes and tumour progression.

    abstract::DNA damage response (DDR), the guardian of genomic integrity, emerges as an oncogene-inducible biological barrier against progression of cancer beyond its early stages. Recent evidence from both cell culture and animal models as well as analyses of clinical specimens show that activation of numerous oncogenes and loss...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210881

    authors: Bartek J,Bartkova J,Lukas J

    更新日期:2007-12-10 00:00:00

  • The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.

    abstract::Inter-alpha-trypsin inhibitors (ITIs) are protease inhibitors stabilizing the extracellular matrix. ITIs consist of one light (bikunin) and two heavy chains (ITIHs). We have recently characterized ITIH5, a novel member of the ITIH gene family, and showed that its messenger RNA is lost in a high proportion of breast tu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210669

    authors: Veeck J,Chorovicer M,Naami A,Breuer E,Zafrakas M,Bektas N,Dürst M,Kristiansen G,Wild PJ,Hartmann A,Knuechel R,Dahl E

    更新日期:2008-01-31 00:00:00

  • Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes.

    abstract::Antioxidant response element (ARE)-mediated expression and coordinated induction of genes encoding detoxifying enzymes is one mechanism of critical importance to cellular protection against oxidative stress. In the present report, we demonstrate that nuclear transcription factors Nrf2 and Nrf1 associate with Jun (c-Ju...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202237

    authors: Venugopal R,Jaiswal AK

    更新日期:1998-12-17 00:00:00

  • Leukemic cell line, KG-1 has a functional loss of hOGG1 enzyme due to a point mutation and 8-hydroxydeoxyguanosine can kill KG-1.

    abstract::We tested the cytotoxic action of 8-hydroxyguanine (8ohG) by observing the viability of several leukemic cell lines (KG-1, U937, Jurkat and K 562) in the presence of 8-hydroxydeoxyguanosine (8ohdG), a nucleoside of 8ohG. It was found that 8ohdG showed cytotoxic action only to KG-1 and that only KG-1 showed a homozygou...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203787

    authors: Hyun JW,Choi JY,Zeng HH,Lee YS,Kim HS,Yoon SH,Chung MH

    更新日期:2000-09-14 00:00:00

  • Mutations in the thymidine kinase gene that allow expression of the enzyme in quiescent (G0) cells.

    abstract::Thymidine kinase (TK) is a nucleotide salvage pathway enzyme whose activity is highly dependent on the growth state and cell cycle phase of a cell. Cells in the resting or quiescent (G0) phase express very low levels of TK mRNA and protein. When quiescent cells are stimulated to enter the cell cycle by the addition of...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kauffman MG,Rose PA,Kelly TJ

    更新日期:1991-08-01 00:00:00

  • Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis.

    abstract::Mitochondrial membrane permeabilization is a critical event in the process leading to physiological or chemotherapy-induced apoptosis. This permeabilization event is at least in part under the control of the permeability transition pore complex (PTPC), which interacts with oncoproteins from the Bcl-2 family as well as...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203299

    authors: Costantini P,Belzacq AS,Vieira HL,Larochette N,de Pablo MA,Zamzami N,Susin SA,Brenner C,Kroemer G

    更新日期:2000-01-13 00:00:00

  • Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B.

    abstract::SEMA3B, a member of class 3 semaphorins, is a tumor suppressor. Competition with vascular endothelial growth factor (VEGF)165 explains a portion of the activity, whereas the VEGF-independent mechanism was not elucidated. We employed a microarray and screened for the genes whose expression was increased by SEMA3B in NC...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.263

    authors: Koyama N,Zhang J,Huqun,Miyazawa H,Tanaka T,Su X,Hagiwara K

    更新日期:2008-11-20 00:00:00

  • NFATc2 is an intrinsic regulator of melanoma dedifferentiation.

    abstract::Melanoma dedifferentiation, characterized by the loss of MITF and MITF regulated genes and by upregulation of stemness markers as CD271, is implicated in resistance to chemotherapy, target therapy and immunotherapy. The identification of intrinsic mechanisms fostering melanoma dedifferentiation may provide actionable ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.355

    authors: Perotti V,Baldassari P,Molla A,Vegetti C,Bersani I,Maurichi A,Santinami M,Anichini A,Mortarini R

    更新日期:2016-06-02 00:00:00

  • PCR-based identification of new receptors: molecular cloning of a receptor for fibroblast growth factors.

    abstract::Transmembrane tyrosine kinases are involved in the control of cell growth and differentiation by extracellular signals. To enable identification of new receptor tyrosine kinases we developed a method that selectively amplifies segments of receptor genes. The method is based on a combination of polymerase chain reactio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Raz V,Kelman Z,Avivi A,Neufeld G,Givol D,Yarden Y

    更新日期:1991-05-01 00:00:00

  • Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.

    abstract::Angiogenesis is essential for tumor growth and blocking this process might be a valid tool for the control of cancer growth. We showed previously that tumor angiogenesis in integrin alpha1-null mice is reduced compared to that of wild type animals and that over-expression of matrix metalloproteinase 9 (MMP-9) in the a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205045

    authors: Pozzi A,LeVine WF,Gardner HA

    更新日期:2002-01-10 00:00:00

  • Autocrine HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell leukemia/lymphoma.

    abstract::Adult T-cell leukemia/lymphoma (ATL) is an aggressive T-cell neoplasm. While ATL cells in peripheral blood (PB-ATL) are sensitive to anti-CC chemokine receptor 4 treatment, non-PB-ATLs, including lymph node ATLs (LN-ATLs), are more aggressive and resistant. We examined characteristic cytokines and growth factors that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01393-x

    authors: Totani H,Shinjo K,Suzuki M,Katsushima K,Mase S,Masaki A,Ito A,Ri M,Kusumoto S,Komatsu H,Ishida T,Inagaki H,Iida S,Kondo Y

    更新日期:2020-08-01 00:00:00

  • Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation.

    abstract::We have identified the mouse telomerase reverse transcriptase component (mTERT) and demonstrate both substantial sequence homology to the human ortholog (hTERT), and the presence of reverse transcriptase and telomerase specific motifs. Furthermore, we show functional interchangeability with hTERT in in vitro telomeras...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201933

    authors: Greenberg RA,Allsopp RC,Chin L,Morin GB,DePinho RA

    更新日期:1998-04-02 00:00:00

  • Characterization of a major colon cancer susceptibility locus (Ccs3) on mouse chromosome 3.

    abstract::Treatment of mice with the carcinogen azoxymethane (AOM) induces a number of lesions in the colon, including hyperplastic lesions, as well adenomas and carcinomas in situ. Inbred strains of mice show different responses to AOM-induced carcinogenesis. A/J mice are highly susceptible and develop a greater number of hype...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.369

    authors: Meunier C,Cai J,Fortin A,Kwan T,Marquis JF,Turbide C,Van Der Kraak L,Jothy S,Beauchemin N,Gros P

    更新日期:2010-02-04 00:00:00

  • Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.

    abstract::Mdm2 is the major negative regulator of p53 tumor-suppressor activity. This oncoprotein is overexpressed in many human tumors that retain the wild-type p53 allele. As such, targeted inhibition of Mdm2 is being considered as a therapeutic anticancer strategy. The N-terminal hydrophobic pocket of Mdm2 binds to p53 and t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.625

    authors: Wade M,Li YC,Matani AS,Braun SM,Milanesi F,Rodewald LW,Wahl GM

    更新日期:2012-11-08 00:00:00

  • Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors.

    abstract::We report the detailed molecular characterization of a human parathyroid adenoma with a clonal parathyroid hormone gene rearrangement. This rearrangement is similar to one we characterized recently in an independent adenoma. In these two, plus a third partially characterized adenoma, one allele of the PTH gene, on 11p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Rosenberg CL,Kim HG,Shows TB,Kronenberg HM,Arnold A

    更新日期:1991-03-01 00:00:00

  • Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway.

    abstract::B-Myb, a highly conserved member of the Myb oncoprotein family, is a 110 kDa sequence-specific DNA binding protein expressed in virtually all proliferating cells. B-myb expression reaches its maximum at the G1/S phase boundary and during the S phase of the cell cycle. We have previously shown that B-Myb activity is ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203618

    authors: Charrasse S,Carena I,Brondani V,Klempnauer KH,Ferrari S

    更新日期:2000-06-15 00:00:00

  • A functional link between the tumour suppressors ARF and p33ING1.

    abstract::The ARF tumour suppressor protein plays a critical role in the activation of p53 in response to oncogenic stress. ARF can activate p53 through nucleolar sequestration of Mdm2. However, several lines of evidence indicate that this is not the only way of action of ARF, and alternative mechanisms must exist. p33ING1 is a...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209526

    authors: González L,Freije JM,Cal S,López-Otín C,Serrano M,Palmero I

    更新日期:2006-08-24 00:00:00

  • Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas.

    abstract::The current model for colorectal tumorigenesis defines four specific mutations (activation of a ras proto-oncogene and inactivation of the APC, p53 and DCC tumor-suppressor genes) that accumulate in a colonic epithelial cell as it progresses towards a carcinoma. However, further mutations must be needed for progressio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Young J,Leggett B,Ward M,Thomas L,Buttenshaw R,Searle J,Chenevix-Trench G

    更新日期:1993-03-01 00:00:00

  • The FoxO code.

    abstract::The FoxO family of Forkhead transcription factors plays an important role in longevity and tumor suppression by upregulating target genes involved in stress resistance, metabolism, cell cycle arrest and apoptosis. FoxO transcription factors translate a variety of environmental stimuli, including insulin, growth factor...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2008.21

    authors: Calnan DR,Brunet A

    更新日期:2008-04-07 00:00:00

  • Modulation of cellular apoptotic potential: contributions to oncogenesis.

    abstract::The importance of apoptosis as a natural means to eliminate unwanted or damaged cells has been realized over the past decade. Many components required to exercise programmed cell death have been identified and shown to pre-exist in most, if not all, cells. Such ubiquity requires that apoptosis be tightly controlled an...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1203126

    authors: Stambolic V,Mak TW,Woodgett JR

    更新日期:1999-11-01 00:00:00

  • A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants.

    abstract::Genetic mutations in BRCA1, which is crucial for the process of DNA repair and maintenance of genomic integrity, are known to increase markedly the risk of breast and ovarian cancers. Clinical genetic testing has been used to identify new BRCA1 variants; however, functional assessment and determination of their pathog...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0968-2

    authors: Kweon J,Jang AH,Shin HR,See JE,Lee W,Lee JW,Chang S,Kim K,Kim Y

    更新日期:2020-01-01 00:00:00